{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:06:28Z","timestamp":1790816788564,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00080"],"award-info":[{"award-number":["PI17\/00080"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40620-021-01007-z","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T11:03:40Z","timestamp":1615806220000},"page":"1897-1905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis"],"prefix":"10.1093","volume":"34","author":[{"given":"Manuel Ferreira","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mardones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Xipell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Garc\u00eda-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-8476","authenticated-orcid":false,"given":"Luis F.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"issue":"5","key":"1007_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/ar3378","volume":"13","author":"R Saxena","year":"2011","unstructured":"Saxena R, Mahajan T, Mohan C (2011) Lupus nephritis: current update. Arthritis Res Ther 13(5):240. https:\/\/doi.org\/10.1186\/ar3378","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"1007_CR2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"GK Bertsias","year":"2012","unstructured":"Bertsias GK, Tektonidou M, Amoura Z et al (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and pediatric lupus nephritis. Ann Rheum Dis 71(11):1771\u20131782. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201940","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1007_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/art.21625","volume":"54","author":"Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria","year":"2006","unstructured":"Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria (2006) The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 54(2):421\u2013432. https:\/\/doi.org\/10.1002\/art.21625","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1007_CR4","doi-asserted-by":"publisher","first-page":"e000389","DOI":"10.1136\/lupus-2020-000389","volume":"7","author":"I Parodis","year":"2020","unstructured":"Parodis I, Tamirou F, Houssiau FA (2020) Prediction of prognosis and renal outcome in lupus nephritis. Lupus Sci Med 7(1):e000389. https:\/\/doi.org\/10.1136\/lupus-2020-000389","journal-title":"Lupus Sci Med"},{"issue":"4","key":"1007_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/1759720X13485503","volume":"5","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kao AH, Manzi S, Ahearn JM (2013) Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis 5(4):210\u2013233. https:\/\/doi.org\/10.1177\/1759720X13485503","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"1007_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/ndt\/gfv102","volume":"31","author":"S Wilhelmus","year":"2016","unstructured":"Wilhelmus S, Bajema IM, Bertsias GK et al (2016) Lupus nephritis management guidelines compared. Nephrol Dial Transplant 31(6):904\u2013913. https:\/\/doi.org\/10.1093\/ndt\/gfv102","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1007_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2215\/CJN.03400412","volume":"8","author":"G Giannico","year":"2013","unstructured":"Giannico G, Fogo AB (2013) Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol 8(1):138\u2013145. https:\/\/doi.org\/10.2215\/CJN.03400412","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1007_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.asn.0000108969.21691.5d","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241\u2013250. https:\/\/doi.org\/10.1097\/01.asn.0000108969.21691.5d","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1007_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ki.2010.13","volume":"77","author":"F Yu","year":"2010","unstructured":"Yu F, Wu L-H, Tan Y et al (2010) Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77(9):820\u2013829. https:\/\/doi.org\/10.1038\/ki.2010.13","journal-title":"Kidney Int"},{"issue":"5","key":"1007_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/ki.1975.47","volume":"7","author":"JR Brentjens","year":"1975","unstructured":"Brentjens JR, Sepulveda M, Baliah T et al (1975) Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int 7(5):342\u2013350. https:\/\/doi.org\/10.1038\/ki.1975.47","journal-title":"Kidney Int"},{"issue":"8","key":"1007_CR11","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1007_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acr.20441","volume":"63","author":"C Hsieh","year":"2011","unstructured":"Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR (2011) Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res 63(6):865\u2013874. https:\/\/doi.org\/10.1002\/acr.20441","journal-title":"Arthritis Care Res"},{"issue":"4","key":"1007_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ki.1984.75","volume":"25","author":"HA Austin","year":"1984","unstructured":"Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25(4):689\u2013695. https:\/\/doi.org\/10.1038\/ki.1984.75","journal-title":"Kidney Int"},{"issue":"2","key":"1007_CR14","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"issue":"3","key":"1007_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363\u2013369. https:\/\/doi.org\/10.1002\/art.1780390303","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1007_CR16","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/art.40575","volume":"70","author":"A Londo\u00f1o Jimenez","year":"2018","unstructured":"Londo\u00f1o Jimenez A, Mowrey WB, Putterman C, Buyon J, Goilav B, Broder A (2018) Brief report: tubulointerstitial damage in lupus nephritis: a comparison of the factors associated with tubulointerstitial inflammation and renal scarring. Arthritis Rheumatol 70(11):1801\u20131806. https:\/\/doi.org\/10.1002\/art.40575","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1007_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2215\/CJN.10601016","volume":"12","author":"EC Rijnink","year":"2017","unstructured":"Rijnink EC, Teng YKO, Wilhelmus S et al (2017) Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis. Clin J Am Soc Nephrol 12(5):734\u2013743. https:\/\/doi.org\/10.2215\/CJN.10601016","journal-title":"Clin J Am Soc Nephrol"},{"key":"1007_CR18","doi-asserted-by":"crossref","unstructured":"Jovanovic B, Khan HN, Mowrey W, Izmirly PM, Schwartz D, Buyon JP, Putterman C, Goilav B BA. Tubulointerstitial damage is an independent predictor of end stage renal disease in lupus nephritis patients with mild to moderate renal impairment [abstract]. Arthritis Rheumatol. 2016;68(suppl). https:\/\/acrabstracts.org\/abstract\/tubulointerstitial-damage-is-an-independent-predictor-of-end-stage-renal-disease-in-lupus-nephritis-patients-with-mild-to-moderate-renal-impairment\/.","DOI":"10.1136\/annrheumdis-2016-eular.2288"},{"issue":"5","key":"1007_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.semnephrol.2015.08.007","volume":"35","author":"MR Clark","year":"2015","unstructured":"Clark MR, Trotter K, Chang A (2015) The pathogenesis and therapeutic implications of tubulointerstitial inflammation in human lupus nephritis. Semin Nephrol 35(5):455\u2013464. https:\/\/doi.org\/10.1016\/j.semnephrol.2015.08.007","journal-title":"Semin Nephrol"},{"issue":"5","key":"1007_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/rheumatology\/ken019","volume":"47","author":"N Hiramatsu","year":"2008","unstructured":"Hiramatsu N, Kuroiwa T, Ikeuchi H et al (2008) Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology 47(5):702\u2013707. https:\/\/doi.org\/10.1093\/rheumatology\/ken019","journal-title":"Rheumatology"},{"issue":"5","key":"1007_CR21","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1046\/j.1523-1755.2001.00017.x","volume":"60","author":"GS Hill","year":"2001","unstructured":"Hill GS, Delahousse M, Nochy D, Mandet C, Bari\u00e9ty J (2001) Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 60(5):1893\u20131903. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00017.x","journal-title":"Kidney Int"},{"issue":"3","key":"1007_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.semarthrit.2019.06.002","volume":"49","author":"C Leatherwood","year":"2019","unstructured":"Leatherwood C, Speyer CB, Feldman CH et al (2019) Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies. Semin Arthritis Rheum 49(3):396\u2013404. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.002","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"1007_CR23","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/art.21039","volume":"52","author":"BJ Fessler","year":"2005","unstructured":"Fessler BJ, Alarc\u00f3n GS, McGwin G et al (2005) Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 52(5):1473\u20131480. https:\/\/doi.org\/10.1002\/art.21039","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1007_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1191\/0961203306lu2313oa","volume":"15","author":"N Kasitanon","year":"2006","unstructured":"Kasitanon N, Fine DM, Haas M, Magder LS, Petri M (2006) Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus 15(6):366\u2013370. https:\/\/doi.org\/10.1191\/0961203306lu2313oa","journal-title":"Lupus"},{"issue":"3","key":"1007_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155\u2013166. https:\/\/doi.org\/10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1007_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/nep.12555","volume":"21","author":"F Pagni","year":"2016","unstructured":"Pagni F, Galimberti S, Galbiati E et al (2016) Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy. Nephrology (Carlton) 21(1):35\u201345. https:\/\/doi.org\/10.1111\/nep.12555","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"1007_CR27","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1046\/j.1523-1755.2000.00272.x","volume":"58","author":"GS Hill","year":"2000","unstructured":"Hill GS, Delahousse M, Nochy D et al (2000) A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 58(3):1160\u20131173. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00272.x","journal-title":"Kidney Int"},{"issue":"3","key":"1007_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000330356","volume":"34","author":"J Lu","year":"2011","unstructured":"Lu J, Tam L-S, Lai FM-M et al (2011) Repeat renal biopsy in lupus nephritis: a change in histological pattern is common. Am J Nephrol 34(3):220\u2013225. https:\/\/doi.org\/10.1159\/000330356","journal-title":"Am J Nephrol"},{"issue":"5","key":"1007_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41584-020-0401-9","volume":"16","author":"NI Maria","year":"2020","unstructured":"Maria NI, Davidson A (2020) Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy. Nat Rev Rheumatol 16(5):255\u2013267","journal-title":"Nat Rev Rheumatol"},{"key":"1007_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fped.2019.00306","volume":"7","author":"AL Oliverio","year":"2019","unstructured":"Oliverio AL, Bellomo T, Mariani LH (2019) Evolving clinical applications of tissue transcriptomics in kidney disease. Front Pediatr 7:306. https:\/\/doi.org\/10.3389\/fped.2019.00306","journal-title":"Front Pediatr"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01007-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-021-01007-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01007-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:48Z","timestamp":1777564488000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/34\/6\/1897\/8325732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1007\/s40620-021-01007-z","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"28 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The Institutional Review Board of the Hospital Cl\u00ednic of Barcelona approved the study. Informed consent was obtained from the subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}